Funded Startups in Renens
Across these 13 Renens-based funding rounds, the largest disclosed amount is SWISSto12 at $28M (2023-09-13).
Across these 13 Renens-based funding rounds, the largest disclosed amount is SWISSto12 at $28M (2023-09-13). That figure stands out against the rest of the disclosed rounds, which range from $100K (KimboCare, 2020-10-01) up to $6M (Testmate Health, 2024-05-02; Odne, 2024-03-13), with only Astrocast at $18M (2023-04-03) in the higher band.
The dates cluster heavily in the more recent half of the window: three rounds land in 2024 (PAVE Space on 2025-06-26 is the latest, while ClearSpace on 2024-09-13, Aspivix on 2024-06-27, and Testmate Health on 2024-05-02 bracket a dense mid-year stretch), and five biotechnology-linked companies appear across 2021–2024 (Flowbone 2022-10-05, SwissDeCode 2021-01-25, SEED Biosciences 2023-05-10, Aspivix 2024-06-27, Testmate Health 2024-05-02). Stage/classification is often non-specific: 5 of 13 entries are marked “Series Unknown” and 2 are explicitly “undisclosed,” while only a few show named stages (e.g., Seed at Testmate Health $6M on 2024-05-02, and SWISSto12 remains “Series Unknown”).
Most recent rounds
13 shownRelated listings
Frequently asked
What’s the largest disclosed round in Renens on this list, and is it an outlier versus the rest?
SWISSto12’s $28M on 2023-09-13 is the largest disclosed amount, and it sits well above the typical $2M–$6M range seen for entries like Hydromea $2M (2023-05-11) and Odne $6M (2024-03-13). Astrocast’s $18M on 2023-04-03 is the only other disclosed round in the higher band.
How concentrated are recent rounds in time compared with the older end of the displayed window?
The displayed rounds span 2020-10-01 (KimboCare $100K) through 2025-06-26 (PAVE Space $130K). Recent years include multiple 2024 closings—ClearSpace $3M (2024-09-13), Aspivix $560K (2024-06-27), and Testmate Health $6M (2024-05-02)—whereas the older edge includes smaller disclosed amounts such as KimboCare $100K (2020-10-01) and SwissDeCode $4M (2021-01-25).
Which sectors appear often enough to form a cluster across these 13 companies?
Biotechnology is the most repeated sector, appearing in at least 5 entries: Flowbone (2022-10-05, $2M), SwissDeCode (2021-01-25, $4M), SEED Biosciences (2023-05-10, undisclosed), Aspivix (2024-06-27, $560K), and Testmate Health (2024-05-02, Seed, $6M). This concentration is stronger than other sectors, which typically show up once or twice in the list.
What does the stage/classification look like—does it skew toward non-disclosed rounds?
Non-specific labeling is common: 5 of 13 entries are “Series Unknown” (e.g., PAVE Space 2025-06-26 $130K; ClearSpace 2024-09-13 $3M) and 2 of 13 are explicitly “undisclosed” (KITRO 2024-11-27; SEED Biosciences 2023-05-10). Only a few rows show a named stage, including Seed for Testmate Health ($6M on 2024-05-02) and Flowbone (Seed, $2M on 2022-10-05).
Are there small-ticket rounds that materially undercut the disclosed distribution?
Yes. KimboCare’s $100K on 2020-10-01 is the smallest disclosed amount, and it is far below other low-to-mid disclosed rounds such as PAVE Space $130K (2025-06-26) and Aspivix $560K (2024-06-27). Those $130K–$560K figures remain small compared with the multi-million rounds like Testmate Health $6M (2024-05-02) and Odne $6M (2024-03-13).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.